The Greenbrier Companies (GBX) Announces Earnings Results

The Greenbrier Companies (NYSE:GBX) released its earnings results on Friday. The transportation company reported $1.02 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.97 by $0.05, Briefing.com reports. The Greenbrier Companies had a net margin of 5.39% and a return on equity of 10.71%. The business had revenue of $629.30 million for the quarter, compared to analyst estimates of $612.51 million. During the same period last year, the company posted $1.09 EPS. The business’s revenue was up 11.1% on a year-over-year basis.

GBX opened at $47.60 on Friday. The company has a debt-to-equity ratio of 0.47, a quick ratio of 2.04 and a current ratio of 2.96. The Greenbrier Companies has a 1-year low of $41.45 and a 1-year high of $54.45. The company has a market capitalization of $1,366.17, a price-to-earnings ratio of 12.49, a price-to-earnings-growth ratio of 1.21 and a beta of 1.53.

How to Become a New Pot Stock Millionaire

In other The Greenbrier Companies news, EVP Alejandro Centurion sold 5,000 shares of the firm’s stock in a transaction that occurred on Wednesday, January 17th. The shares were sold at an average price of $52.00, for a total value of $260,000.00. Following the transaction, the executive vice president now directly owns 13,523 shares of the company’s stock, valued at approximately $703,196. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 2.46% of the company’s stock.

A number of research firms have weighed in on GBX. ValuEngine raised shares of The Greenbrier Companies from a “buy” rating to a “strong-buy” rating in a research note on Sunday, December 31st. Seaport Global Securities began coverage on shares of The Greenbrier Companies in a research note on Thursday, January 4th. They issued a “buy” rating and a $65.00 target price on the stock. Finally, Zacks Investment Research lowered shares of The Greenbrier Companies from a “buy” rating to a “hold” rating in a research note on Monday, March 12th. One analyst has rated the stock with a sell rating, one has issued a hold rating and seven have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $57.86.

ILLEGAL ACTIVITY WARNING: This piece of content was originally posted by Ticker Report and is owned by of Ticker Report. If you are accessing this piece of content on another domain, it was illegally copied and republished in violation of U.S. and international trademark & copyright law. The legal version of this piece of content can be viewed at https://www.tickerreport.com/banking-finance/3340773/the-greenbrier-companies-gbx-announces-earnings-results.html.

About The Greenbrier Companies

The Greenbrier Companies, Inc designs, manufactures, and markets railroad freight car equipment in North America and Europe. Its Manufacturing segment offers double-stack intermodal railcars; tank cars; auto-max and multi-max products for the transportation of light vehicles; conventional railcars, such as covered hopper cars, boxcars, center partition cars, bulkhead flat cars, and solid waste service flat cars; and pressurized tank cars, non-pressurized tank cars, coil cars, coal cars, gondolas, sliding wall cars, and automobile transporter cars; and marine vessels, including conventional deck barges, double-hull tank barges, railcar/deck barges, barges for aggregates, and other heavy industrial products and dump barges.

Earnings History for The Greenbrier Companies (NYSE:GBX)

Receive News & Ratings for The Greenbrier Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Greenbrier Companies and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Franko Market Capitalization Tops $115,130.00
Franko Market Capitalization Tops $115,130.00
Pluristem Therapeutics  Given a $3.00 Price Target by Maxim Group Analysts
Pluristem Therapeutics Given a $3.00 Price Target by Maxim Group Analysts
Ripio Credit Network  Trading 28.5% Higher  Over Last Week
Ripio Credit Network Trading 28.5% Higher Over Last Week
Triaconta  Price Hits $6.44 on Top Exchanges
Triaconta Price Hits $6.44 on Top Exchanges
Sysco  and Domino’s Pizza  Critical Comparison
Sysco and Domino’s Pizza Critical Comparison
Universal Display  and AVX  Head to Head Comparison
Universal Display and AVX Head to Head Comparison


© 2006-2018 Ticker Report. Google+.